Passive Transdermal Drug Delivery Market Report

Global and Region Passive Transdermal Drug Delivery Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：160
  • REPORT CODE：GMM1008000
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Passive Transdermal Drug Delivery market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Passive Transdermal Drug Deliverymarket, defines the market attractiveness level of Passive Transdermal Drug Delivery market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Passive Transdermal Drug Delivery industry, describes the types of Passive Transdermal Drug Delivery market, the applications of major players and the market size, and deeply analyzes the current situation of the global Passive Transdermal Drug Delivery market and the development prospects and opportunities of Passive Transdermal Drug Delivery industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Passive Transdermal Drug Delivery market in Chapter 13.

    By Player:

    • Johnson & Johnson (Janssen Pharmaceuticals Inc)

    • Bayer AG

    • Noven Pharmaceuticals, Inc

    • Mylan NV

    • Novartis AG

    • Echo Therapeutics, Inc

    • Actavis, Inc

    • 3M

    • Boehringer Ingelheim GmbH

    • Corium International, Inc

    • GlaxoSmithKline plc

    • Transdermal Corp

    By Type:

    • Microfluidics

    • Smart Pill Technology (SPT)

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Passive Transdermal Drug Delivery Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Passive Transdermal Drug Delivery Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Passive Transdermal Drug Delivery Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Passive Transdermal Drug Delivery Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Passive Transdermal Drug Delivery Market Analysis and Outlook to 2022

    • 7.1 Global Passive Transdermal Drug Delivery Consumption (2017-2022)

    • 7.2 United States Passive Transdermal Drug Delivery Consumption (2017-2022)

    • 7.3 Europe Passive Transdermal Drug Delivery Consumption (2017-2022)

    • 7.4 China Passive Transdermal Drug Delivery Consumption (2017-2022)

    • 7.5 Japan Passive Transdermal Drug Delivery Consumption (2017-2022)

    • 7.6 India Passive Transdermal Drug Delivery Consumption (2017-2022)

    • 7.7 South Korea Passive Transdermal Drug Delivery Consumption (2017-2022)

    8 Region and Country-wise Passive Transdermal Drug Delivery Market Analysis and Outlook to 2028

    • 8.1 Global Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)

    • 8.2 United States Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)

    • 8.3 Europe Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)

    • 8.4 China Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)

    • 8.5 Japan Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)

    • 8.6 India Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)

    • 8.7 South Korea Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)

    9 Global Passive Transdermal Drug Delivery Market Outlook by Types and Applications to 2022

    • 9.1 Global Passive Transdermal Drug Delivery Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Microfluidics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Smart Pill Technology (SPT) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Passive Transdermal Drug Delivery Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Passive Transdermal Drug Delivery Market Outlook by Types and Applications to 2028

    • 10.1 Global Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Microfluidics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Smart Pill Technology (SPT) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Passive Transdermal Drug Delivery Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Passive Transdermal Drug Delivery Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Passive Transdermal Drug Delivery Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Passive Transdermal Drug Delivery Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Passive Transdermal Drug Delivery Market Competitive Analysis

    • 14.1 Johnson & Johnson (Janssen Pharmaceuticals Inc)

      • 14.1.1 Johnson & Johnson (Janssen Pharmaceuticals Inc) Company Details

      • 14.1.2 Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Product and Service

    • 14.2 Bayer AG

      • 14.2.1 Bayer AG Company Details

      • 14.2.2 Bayer AG Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bayer AG Passive Transdermal Drug Delivery Product and Service

    • 14.3 Noven Pharmaceuticals, Inc

      • 14.3.1 Noven Pharmaceuticals, Inc Company Details

      • 14.3.2 Noven Pharmaceuticals, Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Noven Pharmaceuticals, Inc Passive Transdermal Drug Delivery Product and Service

    • 14.4 Mylan NV

      • 14.4.1 Mylan NV Company Details

      • 14.4.2 Mylan NV Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Mylan NV Passive Transdermal Drug Delivery Product and Service

    • 14.5 Novartis AG

      • 14.5.1 Novartis AG Company Details

      • 14.5.2 Novartis AG Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novartis AG Passive Transdermal Drug Delivery Product and Service

    • 14.6 Echo Therapeutics, Inc

      • 14.6.1 Echo Therapeutics, Inc Company Details

      • 14.6.2 Echo Therapeutics, Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Echo Therapeutics, Inc Passive Transdermal Drug Delivery Product and Service

    • 14.7 Actavis, Inc

      • 14.7.1 Actavis, Inc Company Details

      • 14.7.2 Actavis, Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Actavis, Inc Passive Transdermal Drug Delivery Product and Service

    • 14.8 3M

      • 14.8.1 3M Company Details

      • 14.8.2 3M Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 3M Passive Transdermal Drug Delivery Product and Service

    • 14.9 Boehringer Ingelheim GmbH

      • 14.9.1 Boehringer Ingelheim GmbH Company Details

      • 14.9.2 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product and Service

    • 14.10 Corium International, Inc

      • 14.10.1 Corium International, Inc Company Details

      • 14.10.2 Corium International, Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Corium International, Inc Passive Transdermal Drug Delivery Product and Service

    • 14.11 GlaxoSmithKline plc

      • 14.11.1 GlaxoSmithKline plc Company Details

      • 14.11.2 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product and Service

    • 14.12 Transdermal Corp

      • 14.12.1 Transdermal Corp Company Details

      • 14.12.2 Transdermal Corp Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Transdermal Corp Passive Transdermal Drug Delivery Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Passive Transdermal Drug Delivery

    • Figure Passive Transdermal Drug Delivery Picture

    • Table Global Passive Transdermal Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Passive Transdermal Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Passive Transdermal Drug Delivery Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Passive Transdermal Drug Delivery Consumption by Country (2017-2022)

    • Figure United States Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Europe Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure China Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Japan Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure India Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure South Korea Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Global Passive Transdermal Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure United States Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microfluidics Consumption and Growth Rate (2017-2022)

    • Figure Global Smart Pill Technology (SPT) Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Microfluidics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Smart Pill Technology (SPT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Passive Transdermal Drug Delivery Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Passive Transdermal Drug Delivery Export by Region (Top 5 Countries) (2017-2028)

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Passive Transdermal Drug Delivery Product and Service

    • Table Noven Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Noven Pharmaceuticals, Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Noven Pharmaceuticals, Inc Passive Transdermal Drug Delivery Product and Service

    • Table Mylan NV (Foundation Year, Company Profile and etc.)

    • Table Mylan NV Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan NV Passive Transdermal Drug Delivery Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Passive Transdermal Drug Delivery Product and Service

    • Table Echo Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Echo Therapeutics, Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Echo Therapeutics, Inc Passive Transdermal Drug Delivery Product and Service

    • Table Actavis, Inc (Foundation Year, Company Profile and etc.)

    • Table Actavis, Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis, Inc Passive Transdermal Drug Delivery Product and Service

    • Table 3M (Foundation Year, Company Profile and etc.)

    • Table 3M Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M Passive Transdermal Drug Delivery Product and Service

    • Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product and Service

    • Table Corium International, Inc (Foundation Year, Company Profile and etc.)

    • Table Corium International, Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corium International, Inc Passive Transdermal Drug Delivery Product and Service

    • Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Product and Service

    • Table Transdermal Corp (Foundation Year, Company Profile and etc.)

    • Table Transdermal Corp Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Transdermal Corp Passive Transdermal Drug Delivery Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US